Experts have started thinking more broadly about what puts a person at risk for heart disease, still the leading killer in the U.S.

Denosumab treatment for osteoporosis appears more hazardous in postmenopausal women with advanced chronic kidney disease (CKD).

Kidney disease advocates are calling for earlier treatment, increased research and more organ transplants to end Australia's ...

Chronic kidney disease (CKD) is increasingly recognized as a major global health issue, and disparities in healthcare access ...

Calcium levels decreased less with each subsequent denosumab dose among individuals with osteoporosis and advanced chronic kidney disease.

The Food and Drug Administration (FDA) has added a new boxed warning on the denosumab drug label (brand name: Prolia) to alert clinicians to an increased risk for severe hypocalcemia in patients with ...

The risk for emergently treated hypocalcemia in individuals receiving denosumab peaked at 2 weeks after administration and ...

Researchers at University of Tsukuba have found that the phosphate concentration in proximal tubule fluid, estimated from ...

Fortis Gurugram is committed to delivering world-class healthcare to the patients and supporting the fight against chronic ...

Top data on glomerular disease presented at the 2024 American Society of Nephrology Kidney Week conference include data on atacicept benefits in IgA nephropathy, protein reduction from ...